Peptides and recombinant proteins for COVID-19 research

We offer SARS spike peptides and proteins for multiple research directions such as the development of vaccines and therapeutics against SARS-CoV-2:
At Genaxxon, you can get SARS-CoV-2 (2019-nCoV) spike proteins with diverse key sequence segments.
The spike (S) glycoprotein contains S1 and S2 subunits that mediate binding to and fusion with the human ACE2 transmembrane protein used by the virus as an entry point into the human host cell at the beginning of an infection process.

ACE2 is widely expressed throughout the human body (e.g., in tongue epithelia, B cells, T cells and macrophages in the oral mucosa, type II alveolar cells, and myocardiocytes). Because the S-glycoprotein is essential for ACE2 receptor recognition, binding, and entry into host cells, it is lein logical antigenic target for the development of a SARS-CoV-2 vaccine and therapeutics in COVID-19 treatment.
Xu et al. "High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa." Int J Oral Sci 12, 8 (2020). https://doi.org/10.1038/s41368-020-0074-x.

- SARS-CoV-2 (2019-nCoV) spike S1 and S2 proteins, RBD.
- SARS-CoV-2 coronavirus 2019 spike e-mosaic.
- Coronavirus 2019 Nucleocapsid Mosaic Protein.

In the following list, you can choose the SARS spike protein that is most suitable for your research.